home / stock / cdtx / cdtx quote
Last: | $12.51 |
---|---|
Change Percent: | 7.33% |
Open: | $11.75 |
Close: | $12.51 |
High: | $13.1999 |
Low: | $11.75 |
Volume: | 53,967 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$12.51 | $11.75 | $12.51 | $13.1999 | $11.75 | 53,967 | 05-03-2024 |
$12.68 | $11.84 | $12.68 | $12.85 | $11.52 | 65,150 | 05-02-2024 |
$11.81 | $11.85 | $11.81 | $11.86 | $11.0161 | 107,662 | 05-01-2024 |
$11.98 | $12.2 | $11.98 | $12.6351 | $11.72 | 76,446 | 04-30-2024 |
$12.325 | $12.59 | $12.325 | $12.82 | $11.9 | 112,391 | 04-29-2024 |
$12.63 | $12.65 | $12.63 | $13.43 | $11.57 | 200,108 | 04-26-2024 |
$13 | $14.5 | $13 | $14.96 | $12.133 | 753,807 | 04-25-2024 |
$12.29 | $10.18 | $12.29 | $12.59 | $10.1057 | 169,313 | 04-24-2024 |
$0.5125 | $0.5412 | $0.5125 | $0.58 | $0.5002 | 1,864,177 | 04-23-2024 |
$0.5139 | $0.6 | $0.5139 | $0.648 | $0.5002 | 3,853,149 | 04-22-2024 |
$0.681 | $0.705 | $0.681 | $0.74 | $0.68 | 364,913 | 04-19-2024 |
$0.722 | $0.72 | $0.722 | $0.749899 | $0.7151 | 274,327 | 04-18-2024 |
$0.7222 | $0.723 | $0.7222 | $0.8 | $0.7101 | 429,848 | 04-17-2024 |
$0.73 | $0.85 | $0.73 | $0.87 | $0.69 | 1,269,963 | 04-16-2024 |
$0.8247 | $0.87 | $0.8247 | $0.88 | $0.82 | 305,123 | 04-15-2024 |
$0.81 | $0.8641 | $0.81 | $0.8911 | $0.7883 | 538,466 | 04-12-2024 |
$0.8641 | $0.93 | $0.8641 | $0.9599 | $0.8201 | 525,068 | 04-11-2024 |
$0.9201 | $0.82 | $0.9201 | $0.9776 | $0.7801 | 921,011 | 04-10-2024 |
$0.875 | $1.07 | $0.875 | $1.1 | $0.8651 | 1,691,607 | 04-09-2024 |
$1.07 | $1.16 | $1.07 | $1.2 | $1.04 | 1,403,292 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
Cidara Therapeutics Inc. Company Name:
CDTX Stock Symbol:
NASDAQ Market:
Cidara Therapeutics Inc. Website:
NEW YORK, NY / ACCESSWIRE / May 2, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cidara Therapeutics, Inc. ("Cidara" or "the Company") (NASDAQ:CDTX). Investors who purchased Cidara securities are encouraged to obtain additional informa...
SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak&...
SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serio...